| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/16/1999 | CA2122112C Adrenomedullin |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/16/1999 | CA1340398C Bovine placental lactogen gene |
| 02/16/1999 | CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 02/16/1999 | CA1340393C Production of recombinant human psti in saccharomyces cerevisiae |
| 02/16/1999 | CA1340391C Monoclonal antibodies against atrial, natriuretic peptides of humans |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/13/1999 | CA2240607A1 Novel vascular smooth muscle cell growth factor |
| 02/13/1999 | CA2234415A1 A method of identifying agonist and antagonists for tumor necrosis related receptors tr1 and tr2 |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/12/1999 | CA2231728A1 Mray |
| 02/11/1999 | WO1999006840A1 Collagen-peptide assay method |
| 02/11/1999 | WO1999006599A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 02/11/1999 | WO1999006576A1 A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006569A1 Cytotoxic polypeptide (fragment) derived from ribonuclease |
| 02/11/1999 | WO1999006568A1 Bacillus thuringiensis cry6-toxins with improved activity |
| 02/11/1999 | WO1999006567A1 Secretion of carrier-bonded proteins into the periplasma and the extracellular space |
| 02/11/1999 | WO1999006566A1 Production of transgenic poinsettia |
| 02/11/1999 | WO1999006565A2 Antifreeze proteins, dna and expression systems |
| 02/11/1999 | WO1999006564A1 Expression of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens |
| 02/11/1999 | WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | WO1999006561A2 Chemokine receptor ccr8 dna and uses thereof |
| 02/11/1999 | WO1999006560A1 Annexin binding protein |
| 02/11/1999 | WO1999006559A1 Methods to identify growth differentiation factor (gdf) receptors |
| 02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006556A1 Growth differentiation factor-16 |
| 02/11/1999 | WO1999006554A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES |
| 02/11/1999 | WO1999006553A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
| 02/11/1999 | WO1999006552A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
| 02/11/1999 | WO1999006551A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 02/11/1999 | WO1999006550A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
| 02/11/1999 | WO1999006549A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 02/11/1999 | WO1999006548A2 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS |
| 02/11/1999 | WO1999006547A2 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase |
| 02/11/1999 | WO1999006546A1 Human orthologue of ngd5 protein regulated by opiod treatment |
| 02/11/1999 | WO1999006545A2 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 02/11/1999 | WO1999006544A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | WO1999006543A1 Assays for compounds which extend life span |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006537A1 Cross-linked polypeptide assay components |
| 02/11/1999 | WO1999006445A1 Growth differentiation factor-15 |
| 02/11/1999 | WO1999006444A1 GROWTH DIFFERENTIATION FACTOR, Lefty-1 |
| 02/11/1999 | WO1999006443A1 Growth differentiation factor, lefty-2 |
| 02/11/1999 | WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 02/11/1999 | WO1999006441A1 Proteinic product, process for its preparation, compositions containing it and use in medicaments |
| 02/11/1999 | WO1999006440A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 02/11/1999 | WO1999006439A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 02/11/1999 | WO1999006438A2 Compounds with anti-ks and anti-hiv activity |
| 02/11/1999 | WO1999006429A1 Method for stabilizing useful proteins and useful protein compositions |
| 02/11/1999 | WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | WO1999006425A1 Oxidized styrenic polymers for dna binding |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006072A1 Cyclized prodrugs |
| 02/11/1999 | WO1999006069A1 Herpes virus replication defective mutants |
| 02/11/1999 | WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | WO1999006067A1 Method of removing endotoxin from vaccines |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006064A1 Method for preventing and treating hearing loss using a neurturin protein product |
| 02/11/1999 | WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 02/11/1999 | WO1999006061A1 Prediction, detection, and design of t cell epitopes |
| 02/11/1999 | WO1999006034A1 Coup-tfi directed therapies in the treatment of disease |
| 02/11/1999 | WO1999005903A1 Germplasm and molecular markers for disease resistance in potato |
| 02/11/1999 | WO1998050556A3 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
| 02/11/1999 | WO1998050057A3 Agent for enhancing the heart force |
| 02/11/1999 | WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/11/1999 | WO1998049194A3 Ras-like protein |
| 02/11/1999 | WO1998035032A3 Methods of inducing cell cycle stasis |
| 02/11/1999 | DE19832045A1 Protein macromolecule dyes with good colour intensity, fastness and compatibility |
| 02/11/1999 | DE19733899A1 Verfahren und Vorrichtung zur Herstellung autologer, thrombozytärer Wachstumsfaktoren sowie System als Bestandteil einer Vorrichtung zur Herstellung autologer, thrombozytärer Wachtstumsfaktoren Method and apparatus for preparing autologous platelet-derived growth factors as well as a system component of an apparatus for the production of autologous platelet-Wachtstumsfaktoren |
| 02/11/1999 | CA2299620A1 Antifreeze proteins, dna and expression systems |
| 02/11/1999 | CA2299615A1 Expression of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens |
| 02/11/1999 | CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | CA2299054A1 Compounds with anti-ks and anti-hiv activity |
| 02/11/1999 | CA2299052A1 Secretion of carrier-bound proteins into the periplasm and into the extracellular space |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298843A1 Germplasm and molecular markers for disease resistance in potato |
| 02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2298101A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 02/11/1999 | CA2298062A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function |
| 02/11/1999 | CA2297747A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | CA2297745A1 Oxidized styrenic polymers for dna binding |
| 02/11/1999 | CA2297555A1 Collagen-peptide assay method |
| 02/11/1999 | CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | CA2297306A1 5'ests for non tissue specific secreted proteins |
| 02/11/1999 | CA2297157A1 5' ests for secreted proteins expressed in testis and other tissues |